HEADER DNA BINDING PROTEIN 31-MAR-14 4PZO TITLE CRYSTAL STRUCTURE OF PHC3 SAM L967R COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYHOMEOTIC-LIKE PROTEIN 3; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: STERILE ALPHA MOTIF; COMPND 5 SYNONYM: EARLY DEVELOPMENT REGULATORY PROTEIN 3, HOMOLOG OF COMPND 6 POLYHOMEOTIC 3, HPH3; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EDR3, PH3, PHC3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-3C KEYWDS SAM DOMAIN, POLYCOMB GROUP, POLYMER, CHROMATIN, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.R.NANYES,S.E.JUNCO,A.B.TAYLOR,A.K.ROBINSON,N.L.PATTERSON, AUTHOR 2 A.SHIVARAJPUR,J.HALLORAN,S.M.HALE,Y.KAUR,P.J.HART,C.A.KIM REVDAT 4 20-SEP-23 4PZO 1 SEQADV LINK REVDAT 3 15-OCT-14 4PZO 1 JRNL REVDAT 2 20-AUG-14 4PZO 1 JRNL REVDAT 1 30-JUL-14 4PZO 0 JRNL AUTH D.R.NANYES,S.E.JUNCO,A.B.TAYLOR,A.K.ROBINSON,N.L.PATTERSON, JRNL AUTH 2 A.SHIVARAJPUR,J.HALLORAN,S.M.HALE,Y.KAUR,P.J.HART,C.A.KIM JRNL TITL MULTIPLE POLYMER ARCHITECTURES OF HUMAN POLYHOMEOTIC HOMOLOG JRNL TITL 2 3 STERILE ALPHA MOTIF. JRNL REF PROTEINS V. 82 2823 2014 JRNL REFN ISSN 0887-3585 JRNL PMID 25044168 JRNL DOI 10.1002/PROT.24645 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.56 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 32704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.284 REMARK 3 R VALUE (WORKING SET) : 0.282 REMARK 3 FREE R VALUE : 0.335 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.150 REMARK 3 FREE R VALUE TEST SET COUNT : 2010 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.7355 - 5.4191 0.93 2278 151 0.2664 0.3614 REMARK 3 2 5.4191 - 4.3030 0.94 2210 143 0.2623 0.3373 REMARK 3 3 4.3030 - 3.7595 0.94 2204 143 0.2560 0.3341 REMARK 3 4 3.7595 - 3.4160 0.94 2213 142 0.2690 0.3270 REMARK 3 5 3.4160 - 3.1713 0.94 2182 145 0.2787 0.3315 REMARK 3 6 3.1713 - 2.9844 0.94 2194 143 0.2799 0.3295 REMARK 3 7 2.9844 - 2.8349 0.94 2186 140 0.3027 0.3498 REMARK 3 8 2.8349 - 2.7116 0.94 2180 142 0.2950 0.3198 REMARK 3 9 2.7116 - 2.6072 0.94 2189 146 0.3003 0.3221 REMARK 3 10 2.6072 - 2.5173 0.94 2176 140 0.3036 0.3183 REMARK 3 11 2.5173 - 2.4386 0.94 2190 141 0.3237 0.3625 REMARK 3 12 2.4386 - 2.3689 0.94 2155 136 0.3202 0.3713 REMARK 3 13 2.3689 - 2.3065 0.94 2159 145 0.3321 0.3759 REMARK 3 14 2.3065 - 2.2502 0.94 2176 140 0.3378 0.3874 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 47.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3441 REMARK 3 ANGLE : 0.592 4642 REMARK 3 CHIRALITY : 0.025 524 REMARK 3 PLANARITY : 0.002 593 REMARK 3 DIHEDRAL : 15.437 1286 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PZO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000085420. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32712 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 46.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06200 REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.47600 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4PZN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M SODIUM ACETATE, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 61.97200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 25.87250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 61.97200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 25.87250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 909 REMARK 465 GLU A 910 REMARK 465 LYS A 911 REMARK 465 THR A 912 REMARK 465 ARG A 913 REMARK 465 HIS A 985 REMARK 465 HIS A 986 REMARK 465 HIS A 987 REMARK 465 HIS A 988 REMARK 465 HIS A 989 REMARK 465 HIS A 990 REMARK 465 MET B 909 REMARK 465 GLU B 910 REMARK 465 LYS B 911 REMARK 465 THR B 912 REMARK 465 ARG B 984 REMARK 465 HIS B 985 REMARK 465 HIS B 986 REMARK 465 HIS B 987 REMARK 465 HIS B 988 REMARK 465 HIS B 989 REMARK 465 HIS B 990 REMARK 465 MET C 909 REMARK 465 GLU C 910 REMARK 465 LYS C 911 REMARK 465 SER C 983 REMARK 465 ARG C 984 REMARK 465 HIS C 985 REMARK 465 HIS C 986 REMARK 465 HIS C 987 REMARK 465 HIS C 988 REMARK 465 HIS C 989 REMARK 465 HIS C 990 REMARK 465 MET D 909 REMARK 465 GLU D 910 REMARK 465 LYS D 911 REMARK 465 THR D 912 REMARK 465 ARG D 913 REMARK 465 ARG D 984 REMARK 465 HIS D 985 REMARK 465 HIS D 986 REMARK 465 HIS D 987 REMARK 465 HIS D 988 REMARK 465 HIS D 989 REMARK 465 HIS D 990 REMARK 465 MET E 909 REMARK 465 GLU E 910 REMARK 465 LYS E 911 REMARK 465 ARG E 984 REMARK 465 HIS E 985 REMARK 465 HIS E 986 REMARK 465 HIS E 987 REMARK 465 HIS E 988 REMARK 465 HIS E 989 REMARK 465 HIS E 990 REMARK 465 MET F 909 REMARK 465 GLU F 910 REMARK 465 LYS F 911 REMARK 465 THR F 912 REMARK 465 ARG F 984 REMARK 465 HIS F 985 REMARK 465 HIS F 986 REMARK 465 HIS F 987 REMARK 465 HIS F 988 REMARK 465 HIS F 989 REMARK 465 HIS F 990 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 961 -44.64 -148.05 REMARK 500 GLU A 982 -87.25 -67.30 REMARK 500 ASN B 964 -5.54 60.39 REMARK 500 GLU B 982 -5.64 64.81 REMARK 500 ALA C 962 -71.07 -37.36 REMARK 500 MET D 960 -83.66 -71.48 REMARK 500 ASN F 964 88.94 -67.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PZN RELATED DB: PDB DBREF 4PZO A 914 983 UNP Q8NDX5 PHC3_HUMAN 914 983 DBREF 4PZO B 914 983 UNP Q8NDX5 PHC3_HUMAN 914 983 DBREF 4PZO C 914 983 UNP Q8NDX5 PHC3_HUMAN 914 983 DBREF 4PZO D 914 983 UNP Q8NDX5 PHC3_HUMAN 914 983 DBREF 4PZO E 914 983 UNP Q8NDX5 PHC3_HUMAN 914 983 DBREF 4PZO F 914 983 UNP Q8NDX5 PHC3_HUMAN 914 983 SEQADV 4PZO MET A 909 UNP Q8NDX5 INITIATING METHIONINE SEQADV 4PZO GLU A 910 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO LYS A 911 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO THR A 912 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG A 913 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG A 967 UNP Q8NDX5 LEU 967 ENGINEERED MUTATION SEQADV 4PZO ARG A 984 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS A 985 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS A 986 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS A 987 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS A 988 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS A 989 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS A 990 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO MET B 909 UNP Q8NDX5 INITIATING METHIONINE SEQADV 4PZO GLU B 910 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO LYS B 911 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO THR B 912 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG B 913 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG B 967 UNP Q8NDX5 LEU 967 ENGINEERED MUTATION SEQADV 4PZO ARG B 984 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS B 985 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS B 986 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS B 987 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS B 988 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS B 989 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS B 990 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO MET C 909 UNP Q8NDX5 INITIATING METHIONINE SEQADV 4PZO GLU C 910 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO LYS C 911 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO THR C 912 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG C 913 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG C 967 UNP Q8NDX5 LEU 967 ENGINEERED MUTATION SEQADV 4PZO ARG C 984 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS C 985 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS C 986 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS C 987 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS C 988 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS C 989 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS C 990 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO MET D 909 UNP Q8NDX5 INITIATING METHIONINE SEQADV 4PZO GLU D 910 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO LYS D 911 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO THR D 912 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG D 913 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG D 967 UNP Q8NDX5 LEU 967 ENGINEERED MUTATION SEQADV 4PZO ARG D 984 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS D 985 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS D 986 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS D 987 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS D 988 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS D 989 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS D 990 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO MET E 909 UNP Q8NDX5 INITIATING METHIONINE SEQADV 4PZO GLU E 910 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO LYS E 911 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO THR E 912 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG E 913 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG E 967 UNP Q8NDX5 LEU 967 ENGINEERED MUTATION SEQADV 4PZO ARG E 984 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS E 985 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS E 986 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS E 987 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS E 988 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS E 989 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS E 990 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO MET F 909 UNP Q8NDX5 INITIATING METHIONINE SEQADV 4PZO GLU F 910 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO LYS F 911 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO THR F 912 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG F 913 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO ARG F 967 UNP Q8NDX5 LEU 967 ENGINEERED MUTATION SEQADV 4PZO ARG F 984 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS F 985 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS F 986 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS F 987 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS F 988 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS F 989 UNP Q8NDX5 EXPRESSION TAG SEQADV 4PZO HIS F 990 UNP Q8NDX5 EXPRESSION TAG SEQRES 1 A 82 MET GLU LYS THR ARG THR GLU PRO SER ILE TRP THR VAL SEQRES 2 A 82 ASP ASP VAL TRP ALA PHE ILE HIS SER LEU PRO GLY CYS SEQRES 3 A 82 GLN ASP ILE ALA ASP GLU PHE ARG ALA GLN GLU ILE ASP SEQRES 4 A 82 GLY GLN ALA LEU LEU LEU LEU LYS GLU ASP HIS LEU MET SEQRES 5 A 82 SER ALA MET ASN ILE LYS ARG GLY PRO ALA LEU LYS ILE SEQRES 6 A 82 CME ALA ARG ILE ASN SER LEU LYS GLU SER ARG HIS HIS SEQRES 7 A 82 HIS HIS HIS HIS SEQRES 1 B 82 MET GLU LYS THR ARG THR GLU PRO SER ILE TRP THR VAL SEQRES 2 B 82 ASP ASP VAL TRP ALA PHE ILE HIS SER LEU PRO GLY CYS SEQRES 3 B 82 GLN ASP ILE ALA ASP GLU PHE ARG ALA GLN GLU ILE ASP SEQRES 4 B 82 GLY GLN ALA LEU LEU LEU LEU LYS GLU ASP HIS LEU MET SEQRES 5 B 82 SER ALA MET ASN ILE LYS ARG GLY PRO ALA LEU LYS ILE SEQRES 6 B 82 CME ALA ARG ILE ASN SER LEU LYS GLU SER ARG HIS HIS SEQRES 7 B 82 HIS HIS HIS HIS SEQRES 1 C 82 MET GLU LYS THR ARG THR GLU PRO SER ILE TRP THR VAL SEQRES 2 C 82 ASP ASP VAL TRP ALA PHE ILE HIS SER LEU PRO GLY CYS SEQRES 3 C 82 GLN ASP ILE ALA ASP GLU PHE ARG ALA GLN GLU ILE ASP SEQRES 4 C 82 GLY GLN ALA LEU LEU LEU LEU LYS GLU ASP HIS LEU MET SEQRES 5 C 82 SER ALA MET ASN ILE LYS ARG GLY PRO ALA LEU LYS ILE SEQRES 6 C 82 CME ALA ARG ILE ASN SER LEU LYS GLU SER ARG HIS HIS SEQRES 7 C 82 HIS HIS HIS HIS SEQRES 1 D 82 MET GLU LYS THR ARG THR GLU PRO SER ILE TRP THR VAL SEQRES 2 D 82 ASP ASP VAL TRP ALA PHE ILE HIS SER LEU PRO GLY CYS SEQRES 3 D 82 GLN ASP ILE ALA ASP GLU PHE ARG ALA GLN GLU ILE ASP SEQRES 4 D 82 GLY GLN ALA LEU LEU LEU LEU LYS GLU ASP HIS LEU MET SEQRES 5 D 82 SER ALA MET ASN ILE LYS ARG GLY PRO ALA LEU LYS ILE SEQRES 6 D 82 CME ALA ARG ILE ASN SER LEU LYS GLU SER ARG HIS HIS SEQRES 7 D 82 HIS HIS HIS HIS SEQRES 1 E 82 MET GLU LYS THR ARG THR GLU PRO SER ILE TRP THR VAL SEQRES 2 E 82 ASP ASP VAL TRP ALA PHE ILE HIS SER LEU PRO GLY CYS SEQRES 3 E 82 GLN ASP ILE ALA ASP GLU PHE ARG ALA GLN GLU ILE ASP SEQRES 4 E 82 GLY GLN ALA LEU LEU LEU LEU LYS GLU ASP HIS LEU MET SEQRES 5 E 82 SER ALA MET ASN ILE LYS ARG GLY PRO ALA LEU LYS ILE SEQRES 6 E 82 CME ALA ARG ILE ASN SER LEU LYS GLU SER ARG HIS HIS SEQRES 7 E 82 HIS HIS HIS HIS SEQRES 1 F 82 MET GLU LYS THR ARG THR GLU PRO SER ILE TRP THR VAL SEQRES 2 F 82 ASP ASP VAL TRP ALA PHE ILE HIS SER LEU PRO GLY CYS SEQRES 3 F 82 GLN ASP ILE ALA ASP GLU PHE ARG ALA GLN GLU ILE ASP SEQRES 4 F 82 GLY GLN ALA LEU LEU LEU LEU LYS GLU ASP HIS LEU MET SEQRES 5 F 82 SER ALA MET ASN ILE LYS ARG GLY PRO ALA LEU LYS ILE SEQRES 6 F 82 CME ALA ARG ILE ASN SER LEU LYS GLU SER ARG HIS HIS SEQRES 7 F 82 HIS HIS HIS HIS MODRES 4PZO CME A 974 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4PZO CME B 974 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4PZO CME C 974 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4PZO CME D 974 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4PZO CME E 974 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4PZO CME F 974 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 974 10 HET CME B 974 10 HET CME C 974 10 HET CME D 974 10 HET CME E 974 10 HET CME F 974 10 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE FORMUL 1 CME 6(C5 H11 N O3 S2) FORMUL 7 HOH *107(H2 O) HELIX 1 1 GLU A 915 TRP A 919 5 5 HELIX 2 2 THR A 920 SER A 930 1 11 HELIX 3 3 CYS A 934 GLN A 944 1 11 HELIX 4 4 ASP A 947 LEU A 953 1 7 HELIX 5 5 LYS A 955 MET A 960 1 6 HELIX 6 6 LYS A 966 SER A 983 1 18 HELIX 7 7 GLU B 915 TRP B 919 5 5 HELIX 8 8 THR B 920 LEU B 931 1 12 HELIX 9 9 ILE B 937 GLN B 944 1 8 HELIX 10 10 ASP B 947 LEU B 954 1 8 HELIX 11 11 LYS B 955 ASN B 964 1 10 HELIX 12 12 LYS B 966 LYS B 981 1 16 HELIX 13 13 GLU C 915 TRP C 919 5 5 HELIX 14 14 THR C 920 SER C 930 1 11 HELIX 15 15 CYS C 934 GLN C 944 1 11 HELIX 16 16 ASP C 947 LEU C 952 1 6 HELIX 17 17 LYS C 955 SER C 961 1 7 HELIX 18 18 LYS C 966 LYS C 981 1 16 HELIX 19 19 GLU D 915 TRP D 919 5 5 HELIX 20 20 THR D 920 SER D 930 1 11 HELIX 21 21 ASP D 936 GLN D 944 1 9 HELIX 22 22 ASP D 947 LEU D 954 1 8 HELIX 23 23 LYS D 955 MET D 960 1 6 HELIX 24 24 LYS D 966 LYS D 981 1 16 HELIX 25 25 GLU E 915 TRP E 919 5 5 HELIX 26 26 THR E 920 SER E 930 1 11 HELIX 27 27 ILE E 937 GLN E 944 1 8 HELIX 28 28 ASP E 947 LEU E 954 1 8 HELIX 29 29 LYS E 955 ALA E 962 1 8 HELIX 30 30 LYS E 966 LYS E 981 1 16 HELIX 31 31 GLU F 915 TRP F 919 5 5 HELIX 32 32 THR F 920 SER F 930 1 11 HELIX 33 33 CYS F 934 GLN F 944 1 11 HELIX 34 34 ASP F 947 LEU F 952 1 6 HELIX 35 35 LYS F 955 SER F 961 1 7 HELIX 36 36 LYS F 966 LYS F 981 1 16 LINK C ILE A 973 N CME A 974 1555 1555 1.33 LINK C CME A 974 N ALA A 975 1555 1555 1.33 LINK C ILE B 973 N CME B 974 1555 1555 1.33 LINK C CME B 974 N ALA B 975 1555 1555 1.33 LINK C ILE C 973 N CME C 974 1555 1555 1.33 LINK C CME C 974 N ALA C 975 1555 1555 1.33 LINK C ILE D 973 N CME D 974 1555 1555 1.33 LINK C CME D 974 N ALA D 975 1555 1555 1.33 LINK C ILE E 973 N CME E 974 1555 1555 1.33 LINK C CME E 974 N ALA E 975 1555 1555 1.33 LINK C ILE F 973 N CME F 974 1555 1555 1.33 LINK C CME F 974 N ALA F 975 1555 1555 1.33 CRYST1 123.944 51.745 124.020 90.00 119.71 90.00 C 1 2 1 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008068 0.000000 0.004603 0.00000 SCALE2 0.000000 0.019326 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009283 0.00000